Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Fusion pharma Logo
Fusion pharma CB Rank
1857732
Heat Score
57
Fusion pharma is engaged in the development of drugs for the resistant forms of chronic myeloid leukemia.
Founded
obfuscation
Private Moscow, Moscow City, Russian Federation1-10 fusion-pharma.ru
Biotechnology
Health Care
Pharmaceutical
Overview

Fusion pharma
Heat Score
57

Growth Score
pts
in past quarter
Heat Score 57
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Fusion pharma

CB Rank
1857732
Fusion pharma is engaged in the development of drugs for the resistant forms of chronic myeloid leukemia.
Founded
obfuscation
Private Moscow, Moscow City, Russian Federation1-10 fusion-pharma.ru
Biotechnology
Health Care
Pharmaceutical

Key People

Details

Legal Name Fusion pharma LLC
Operating Status Active
Company Type For Profit
Phone Number +7 495 280-07-59
Contact Email info@fusion-pharma.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PF-114 Mesylate
A third-generation Abl tyrosine kinase inhibitor designed to treat resistant chronic myeloid leukemia, including cases with the T315I mutation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Feb 13, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

3Fusion pharma is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 10m, and  Shutterstock.
Sub-Organizations
Frequently Asked Questions

Where is Fusion pharma's headquarters? Fusion pharma is located in Moscow, Moscow City, Russian Federation.Who are Fusion pharma's competitors? Alternatives and possible competitors to Fusion pharma may include Pfizer, Novartis, and  Takeda.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|